Venkata Sasidhar Manda Email and Phone Number
As the Chief Scientific Officer at Apollo Hospital Educational and Research Foundation (AHERF), I lead a team of scientists and clinicians in advancing research and innovation in exosome biology and extracellular vesicles. With over 15 years of experience in this field, I hold a Professional Certification in Biomarkers (PCB) and a PhD in Pharmaceutical Biotechnology from Heinrich Heine University, Düsseldorf.My mission is to develop novel diagnostic and therapeutic solutions for neurodegenerative diseases, such as Alzheimer's and Parkinson's, using cutting-edge exosome engineering techniques. I am also the founder of Urvogelbio, a biotech startup that specializes in exosome-based diagnostics and therapies, and the founder president of the Indian Extracellular Vesicles Society, a platform for fostering collaboration and innovation in this vital field.My approach combines scientific excellence with business acumen, leveraging interdisciplinary partnerships across domains like AI and nanotechnology. I have successfully navigated complex regulatory frameworks globally and secured multiple grants and patents for my work. I am also an avid mentor and educator, supporting emerging scientists and entrepreneurs through various initiatives and programs. As an author of over 25 influential peer-reviewed publications, I strive to communicate science to diverse audiences and bridge the gap between academia, industry, and society.
-
PresidentIndian Extracellular Vesicles SocietyHyderabad, In -
Chief Scientific OfficerApollo Hospitals Educational And Research Foundation (Aherf)-Cmbrc Jun 2017 - PresentHyderabad, Telangana, India -
DirectorUrvogelbio Private Ltd Dec 2017 - PresentHyderabad, Telangana, IndiaAs the Founder of a pioneering startup, I lead the development of cutting-edge exosomal diagnostics tailored for the early detection and management of neurodegenerative diseases. Our proprietary platform leverages advanced exosome profiling to identify biomarkers from blood and saliva, enabling non-invasive diagnostics for Alzheimer's, Parkinson's, and other neurodegenerative conditions.We are also advancing the productization of lab-developed tests into microfluidic assays, enhancing accessibility and scalability. Additionally, we are at the forefront of creating digital twins for neurodegenerative diseases, providing a revolutionary tool for personalized diagnostics and treatment pathways.I oversee all aspects of the business, from research and development to clinical validation and regulatory submissions, while working closely with hospitals, academic institutions, and pharmaceutical companies. Our mission is to transform neurodiagnostics through accessible, precise solutions, shaping the future of personalized medicine. -
FounderUrvogelbio Private Ltd Dec 2017 - Oct 2023Hyderabad Area, IndiaDevelopment of CNS diagnostics and therapeutics using exosome profiling and ocular biomarkers. Portfolio includes Alzheimer disease, Multiple Sclerosis, Stroke and Parkinsons. -
Chief ScientistCell And Molecular Biology Research Centre, Apollo Hospitals Educational And Research Foundation,Hyd Dec 2012 - Aug 2018HyderabadEstablished exosomal platform (EP), and spearheading the development of associated technologies including, biomarkers, drug delivery technology, and therapeutics.Establish clinical biomarker development programs, validation, ensuring alignment with project development plan.Responsible for implementation of interdisciplinary aspects of precision medicine, including biomarkers, correlative science, and personalized medicine.Manages to interface with clinics and genetic service providers for identification and execution of correlative science studies.Develops standard processes for patient selection, stratification, pharmacodynamics and correlative studies for trials by working with internal and external, stakeholders. Partners with the Clinical leadership to identify and validate external companies for, companion diagnostic development and personalized medicine companies.Collection and maintenance of bio-bank samples for assay discovery and validation across multiple disease areas as a part of the CDx development strategy.Evaluate external clinical centers, implement, foster communication, and collaboration with clinical and academic communities to support clinical strategies.
-
Associate Research DirectorApollo Institute Of Medical Sciences And Research Oct 2014 - Mar 2018HyderabadEvaluate external clinical centers, implement, foster communication, and collaboration with the clinical and academic communities.
-
Post Doctoral ResearcherUniversity Of California, Los Angeles Sep 2007 - Jun 2012Los Angeles, Usa.• Discovered roles of new inflammatory genes (IL13RA2, CD40Ligand, and TLR7) and their associated mechanisms in Multiple Sclerosis (MS) and lupus. • Successfully handled and coauthored four translational biology projects involving estradiol and Glucocorticoids in EAE.• Developed expertise in animal model of Multiple sclerosis, Lupus and Autism for conducting translational research -
Executive - ProjectsGvk Bio Aug 2003 - Feb 2004Hyderabad Area, IndiaTechnical due diligence studies for method development of diagnostic kits
-
Executive BioanalystGland Pharma Limited Oct 2001 - Jul 2003Hyderabad Area, India• Liaise with project stakeholders on an ongoing basis to ensure timely and cost effective delivery on in QC projects • Conducted technology transfer in areas of Quality control and Quality assurance of rhGMCSF.• Compilation of regulatory dossiers for market authorization of biosimilars with the Department of Biotechnology and Environmental clearance with Department of Environment, India. -
Executive - Qc And QaVins Bioproducts Ltd Dec 1999 - Sep 2001Hyderabad Area, India• In process testing of Snake venom antiserum• R&D work involved establishment of pilot scale fermentation parameters for extraction of Hyaluronic acid from Streptococcus zooepidemicus -
Msc BiotechnologyAndhra University 1997 - 1999Master thesis - Signal Transduction pathways
Venkata Sasidhar Manda Education Details
-
Pharmaceutical Biotechnology -
Biotechnology -
Biochemistry
Frequently Asked Questions about Venkata Sasidhar Manda
What company does Venkata Sasidhar Manda work for?
Venkata Sasidhar Manda works for Indian Extracellular Vesicles Society
What is Venkata Sasidhar Manda's role at the current company?
Venkata Sasidhar Manda's current role is President.
What schools did Venkata Sasidhar Manda attend?
Venkata Sasidhar Manda attended University Of Düsseldorf, Andhra University, Andhra University, St. Aloysius Anglo Indian High School.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial